United States:
The Law On Damages In Generic Drug Launches Remains Vague
22 January 2014
WilmerHale
To print this article, all you need is to be registered or login on Mondaq.com.
It was a stunning number, purportedly the largest patent
settlement in history. During trial, defendants Teva ($1.6 billion)
and Sun ($550 million) agreed to pay plaintiffs Wyeth and Nycomed a
combined $2.15 billion to settle litigation stemming from their
"at-risk" launches of generic versions of Wyeth and
Nycomed's Protonix product.
To read the full text of this article please click
here.
Originally published in the January 6, 2014 edition of the NEW
YORK LAW JOURNAL © 2014 ALM Media Properties, LLC.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Intellectual Property from United States
Are Your NDAs Up To Date?
Wolf, Greenfield & Sacks, P.C.
Nondisclosure agreements (NDAs) can be used to protect companies' confi dential and trade secret information. But you should resist the urge to have a vendor...
Legal Implications Of New York Times vs. OpenAI
BoyarMiller
The New York Times recently filed a landmark lawsuit against OpenAI and Microsoft, accusing them of copyright infringement in the training of the chatbot ChatGPT which launched just over a year ago.
